1 |
Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, et al. 2013. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152: 1173-1183.
DOI
|
2 |
Kim B, Kim HJ, Lee SJ. 2020. Regulation of microbial metabolic rates using CRISPR interference with expanded PAM sequences. Front. Microbiol. 11: 282.
DOI
|
3 |
Jansen R, van Embden JDA, Gaastra W, Schouls LM. 2002. Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43: 1565-1575.
DOI
|
4 |
Larson MH, Gilbert LA, Wang X, Lim WA, Weissman JS, Qi LS. 2013. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8: 2180-2196.
DOI
|
5 |
Lee HJ, Kim HJ, Lee SJ. 2021. Mismatch intolerance of 5'-truncated sgRNAs in CRISPR/Cas9 enables efficient microbial single-base genome editing. Int. J. Mol. Sci. 22: 6457.
DOI
|
6 |
Lee HJ, Lee SJ. 2021. Advances in accurate microbial genome-editing CRISPR technologies. J. Microbiol. Biotechnol. 31: 903-911.
DOI
|
7 |
Jinek M, Jiang F, Taylor DW, Sternberg SH, Kaya E, Ma E, et al. 2014. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343: 1247997.
DOI
|
8 |
Jiang W, Bikard D, Cox D, Zhang F, Marraffini LA. 2013. RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31: 233-239.
DOI
|
9 |
Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, et al. 2013. Multiplex genome engineering using CRISPR/Cas systems. Science 339: 819-823.
DOI
|
10 |
Bikard D, Jiang W, Samai P, Hochschild A, Zhang F, Marraffini LA. 2013. Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41: 7429-7437.
DOI
|
11 |
Fu YF, Sander JD, Reyon D, Cascio VM, Joung JK. 2014. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32: 279-284.
DOI
|
12 |
Moghadam F, LeGraw R, Velazquez JJ, Yeo NC, Xu C, Park J, et al. 2020. Synthetic immunomodulation with a CRISPR super-repressor in vivo. Nat. Cell Biol. 22: 1143-1154.
DOI
|
13 |
Khakimzhan A, Garenne D, Tickman B, Fontana J, Carothers J, Noireaux V. 2021. Complex dependence of CRISPR-Cas9 binding strength on guide RNA spacer lengths. Phys. Biol. 18: 056003.
DOI
|
14 |
Horvath P, Barrangou R. 2010. CRISPR/Cas, the immune system of bacteria and archaea. Science 327: 167-170.
DOI
|
15 |
Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816-821.
DOI
|
16 |
Nishimasu H, Shi X, Ishiguro S, Gao L, Hirano S, Okazaki S, et al. 2018. Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361: 1259-1262.
DOI
|
17 |
Kim B, Kim HJ, Lee SJ. 2020. Effective blocking of microbial transcriptional initiation by dCas9-NG-mediated CRISPR interference. J. Microbiol. Biotechnol. 30: 1919-1926.
DOI
|
18 |
Lee HJ, Kim HJ, Lee SJ. 2020. CRISPR-Cas9-mediated pinpoint microbial genome editing aided by target-mismatched sgRNAs. Genome Res. 30: 768-775.
DOI
|